Cargando…
Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317918/ https://www.ncbi.nlm.nih.gov/pubmed/22509248 http://dx.doi.org/10.1371/journal.pone.0032785 |
_version_ | 1782228648352284672 |
---|---|
author | Pasarín, Marcos La Mura, Vincenzo Gracia-Sancho, Jorge García-Calderó, Héctor Rodríguez-Vilarrupla, Aina García-Pagán, Juan Carlos Bosch, Jaime Abraldes, Juan G. |
author_facet | Pasarín, Marcos La Mura, Vincenzo Gracia-Sancho, Jorge García-Calderó, Héctor Rodríguez-Vilarrupla, Aina García-Pagán, Juan Carlos Bosch, Jaime Abraldes, Juan G. |
author_sort | Pasarín, Marcos |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endothelial dysfunction within the hepatic vasculature is unknown. The aims of this study were to explore, in a model of diet-induced overweight that expresses most features of the metabolic syndrome, whether early NAFLD is associated with liver endothelial dysfunction. Wistar Kyoto rats were fed a cafeteria diet (CafD; 65% of fat, mostly saturated) or a control diet (CD) for 1 month. CafD rats developed features of the metabolic syndrome (overweight, arterial hypertension, hypertryglyceridemia, hyperglucemia and insulin resistance) and liver steatosis without inflammation or fibrosis. CafD rats had a significantly higher in vivo hepatic vascular resistance than CD. In liver perfusion livers from CafD rats had an increased portal perfusion pressure and decreased endothelium-dependent vasodilation. This was associated with a decreased Akt-dependent eNOS phosphorylation and NOS activity. In summary, we demonstrate in a rat model of the metabolic syndrome that shows features of NAFLD, that liver endothelial dysfunction occurs before the development of fibrosis or inflammation. |
format | Online Article Text |
id | pubmed-3317918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33179182012-04-16 Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD Pasarín, Marcos La Mura, Vincenzo Gracia-Sancho, Jorge García-Calderó, Héctor Rodríguez-Vilarrupla, Aina García-Pagán, Juan Carlos Bosch, Jaime Abraldes, Juan G. PLoS One Research Article Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endothelial dysfunction within the hepatic vasculature is unknown. The aims of this study were to explore, in a model of diet-induced overweight that expresses most features of the metabolic syndrome, whether early NAFLD is associated with liver endothelial dysfunction. Wistar Kyoto rats were fed a cafeteria diet (CafD; 65% of fat, mostly saturated) or a control diet (CD) for 1 month. CafD rats developed features of the metabolic syndrome (overweight, arterial hypertension, hypertryglyceridemia, hyperglucemia and insulin resistance) and liver steatosis without inflammation or fibrosis. CafD rats had a significantly higher in vivo hepatic vascular resistance than CD. In liver perfusion livers from CafD rats had an increased portal perfusion pressure and decreased endothelium-dependent vasodilation. This was associated with a decreased Akt-dependent eNOS phosphorylation and NOS activity. In summary, we demonstrate in a rat model of the metabolic syndrome that shows features of NAFLD, that liver endothelial dysfunction occurs before the development of fibrosis or inflammation. Public Library of Science 2012-04-03 /pmc/articles/PMC3317918/ /pubmed/22509248 http://dx.doi.org/10.1371/journal.pone.0032785 Text en Pasarín et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Pasarín, Marcos La Mura, Vincenzo Gracia-Sancho, Jorge García-Calderó, Héctor Rodríguez-Vilarrupla, Aina García-Pagán, Juan Carlos Bosch, Jaime Abraldes, Juan G. Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD |
title | Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD |
title_full | Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD |
title_fullStr | Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD |
title_full_unstemmed | Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD |
title_short | Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD |
title_sort | sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of nafld |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317918/ https://www.ncbi.nlm.nih.gov/pubmed/22509248 http://dx.doi.org/10.1371/journal.pone.0032785 |
work_keys_str_mv | AT pasarinmarcos sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld AT lamuravincenzo sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld AT graciasanchojorge sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld AT garciacalderohector sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld AT rodriguezvilarruplaaina sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld AT garciapaganjuancarlos sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld AT boschjaime sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld AT abraldesjuang sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld |